Finland· FI-REL-REL8062
Lincocin Vet
A linkomysiini product, registered in Finland by Pfizer Manufacturing Belgium N.V.. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Lincocin is registered in 2 of 19 countries.
Countries holding a registration under ATC QJ01FF02 (linkomysiini), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Lincocin · ATC QJ01FF02
2 / 19 countries
- Denmark
- Finlandprice
The record
At a glance
Fimea (Finland)- Manufacturer
- Pfizer Manufacturing Belgium N.V.
- Country
- Finland (FI)
- ATC code
- QJ01FF02
- ATC class
- Linkomysiini
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under QJ01FF02
Linkomysiini, as other registers publish it.
- FinlandLincocin Premix VetPfizer Manufacturing Belgium N.V.
- FinlandLincocin vetZoetis Animal Health ApS
- FinlandLincocin VetPharmacia Animal Health AB
- FinlandLincocin VetPharmacia & Upjohn Limited
- FinlandLincocin VetPfizer Oy, Animal Health
- FinlandLincomix premix vet.Zoetis Finland Oy
- FinlandLincophar VetEcuphar Veterinaria S.L.U.
- DenmarkLyncooEndectovet EOOD
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6bff3a87-b516-4a41-ab35-c2e66354ecd0 GET /v1/drugs/6bff3a87-b516-4a41-ab35-c2e66354ecd0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "tabletti",
"route": null,
"ddd_unit": null,
"strength": "500 mg",
"atc_label": "Linkomysiini",
"ma_number": "8405",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL8062",
"authorised_at": "1982-11-17"
}See everything about Lincocin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.